The effect was robust for adjustment for COVID-19 exposure; this association was not found for HCoV-OC43 anti-NCt IgA and anti-S IgG, nor for antibodies against other HCoVs, influenza virus and RSV. This evidence concerns the gene CD79A and COVID-19.